glp-1 receptor agonists in idiopathic intracranial hypertension The effect of agonist on hypertension: a systematic review and meta-analysis IIH (Idiopathic Intracranial Hypertension): Symptoms,
Description
GLP-1RA use was significantly associated with a lower risk of all-cause mortality in this cohort compared to insulin/metformin use
In recent years, GLP-1 medications have become a focal point in the medical community due to their innovative treatment mechanisms, significant therapeutic efficacy, and broad development prospects
Pereira, S
Briefly, the first GLP-1RA started with administration twice-daily (BID
Pharmacodynamics, pharmacokinetics, safety, and tolerability of albiglutide, a long-acting glucagon-like peptide-1 mimetic, in patients with type 2 diabetes
